Navidea Biopharmaceuticals, Inc.
(NYSE Amex Equities : NAVB)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
-0.59%93.741.3%$968.18m
BIIBBiogen Inc.
-0.80%225.371.3%$897.71m
GILDGilead Sciences, Inc.
-0.95%62.650.9%$410.31m
AMGNAmgen Inc.
-2.35%178.181.2%$410.07m
ILMNIllumina, Inc.
-0.22%318.003.5%$276.86m
REGNRegeneron Pharmaceuticals, Inc.
-2.52%334.342.6%$236.48m
VRTXVertex Pharmaceuticals Incorporated
0.32%167.501.9%$220.78m
ONCESpark Therapeutics, Inc.
-0.41%110.2611.2%$169.08m
ALXNAlexion Pharmaceuticals, Inc.
-0.49%125.292.0%$164.53m
EXASExact Sciences Corporation
0.15%91.9525.3%$151.34m
SRPTSarepta Therapeutics, Inc.
-1.84%116.5514.7%$138.78m
AAgilent Technologies, Inc.
0.95%76.151.6%$121.23m
INCYIncyte Corporation
-2.19%72.692.5%$89.94m
IONSIonis Pharmaceuticals, Inc.
-0.36%72.418.3%$88.04m
BMRNBioMarin Pharmaceutical Inc.
0.84%83.054.3%$85.35m

Company Profile

Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Dublin, OH.